| 000 | 01532 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250516220300.0 | ||
| 264 | 0 | _c20150202 | |
| 008 | 201502s 0 0 eng d | ||
| 022 | _a1930-6180 | ||
| 024 | 7 |
_a10.1093/ilar/ilu011 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKornegay, Joe N | |
| 245 | 0 | 0 |
_aPharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials. _h[electronic resource] |
| 260 |
_bILAR journal _c2014 |
||
| 300 |
_a119-49 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 |
_aDrug Delivery Systems _xmethods |
| 650 | 0 | 4 |
_aDrug Discovery _xlegislation & jurisprudence |
| 650 | 0 | 4 |
_aDrug Evaluation, Preclinical _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred mdx |
| 650 | 0 | 4 |
_aMuscular Dystrophy, Duchenne _xdrug therapy |
| 650 | 0 | 4 |
_aPharmacogenetics _xmethods |
| 650 | 0 | 4 | _aSpecies Specificity |
| 650 | 0 | 4 |
_aTranslational Research, Biomedical _xmethods |
| 700 | 1 | _aSpurney, Christopher F | |
| 700 | 1 | _aNghiem, Peter P | |
| 700 | 1 | _aBrinkmeyer-Langford, Candice L | |
| 700 | 1 | _aHoffman, Eric P | |
| 700 | 1 | _aNagaraju, Kanneboyina | |
| 773 | 0 |
_tILAR journal _gvol. 55 _gno. 1 _gp. 119-49 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/ilar/ilu011 _zAvailable from publisher's website |
| 999 |
_c23925241 _d23925241 |
||